BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33357227)

  • 1. Medications for attention-deficit/hyperactivity disorder in individuals with or without coexisting autism spectrum disorder: analysis of data from the Swedish prescribed drug register.
    Johansson V; Sandin S; Chang Z; Taylor MJ; Lichtenstein P; D'Onofrio BM; Larsson H; Hellner C; Halldner L
    J Neurodev Disord; 2020 Dec; 12(1):44. PubMed ID: 33357227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish register-based study.
    Dalsgaard S; Nielsen HS; Simonsen M
    J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):432-9. PubMed ID: 24015896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-Response Effects of Long-Acting Liquid Methylphenidate in Children with Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): A Pilot Study.
    Kim SJ; Shonka S; French WP; Strickland J; Miller L; Stein MA
    J Autism Dev Disord; 2017 Aug; 47(8):2307-2313. PubMed ID: 28474229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Young Children with Attention-Deficit/Hyperactivity Disorder and/or Disruptive Behavior Disorders Are More Frequently Prescribed Alpha Agonists Than Stimulants.
    Mittal S; Boan AD; Kral MC; Lally MD; van Bakergem K; Macias MM; LaRosa A
    J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):81-86. PubMed ID: 31621385
    [No Abstract]   [Full Text] [Related]  

  • 5. Processing speed as a marker to stimulant effect in clinical sample of children with high functioning autism spectrum disorder.
    Peled J; Cassuto H; Berger I
    Nord J Psychiatry; 2020 Apr; 74(3):163-167. PubMed ID: 31686565
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of Coexisting Conditions, Attention-Deficit/Hyperactivity Disorder Medication Choice, and Likelihood of Improvement in Preschool-Age Children: A Developmental Behavioral Pediatrics Research Network Study.
    Deavenport-Saman A; Vanderbilt DL; Harstad E; Shults J; Barbaresi W; Bax A; Cacia J; Friedman S; LaRosa A; Loe I; Mittal S; Blum N
    J Child Adolesc Psychopharmacol; 2022 Aug; 32(6):328-336. PubMed ID: 35787014
    [No Abstract]   [Full Text] [Related]  

  • 7. Attention-Deficit/Hyperactivity Disorder Medications and Work Disability and Mental Health Outcomes.
    Taipale H; Bergström J; Gèmes K; Tanskanen A; Ekselius L; Mittendorfer-Rutz E; Helgesson M
    JAMA Netw Open; 2024 Mar; 7(3):e242859. PubMed ID: 38506810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
    Houghton R; Liu C; Bolognani F
    Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication Use in Youth With Autism and Attention-Deficit/Hyperactivity Disorder.
    Rast JE; Anderson KA; Roux AM; Shattuck PT
    Acad Pediatr; 2021 Mar; 21(2):272-279. PubMed ID: 32492579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, Patient Characteristics, and Pharmacological Treatment of Children, Adolescents, and Adults Diagnosed With ADHD in Sweden.
    Giacobini M; Medin E; Ahnemark E; Russo LJ; Carlqvist P
    J Atten Disord; 2018 Jan; 22(1):3-13. PubMed ID: 25376193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of autism spectrum disorder and intellectual disability but not attention deficit/hyperactivity disorder is increased in individuals with esophageal atresia.
    Kassa AM; Håkanson CA; Lilja HE
    Dis Esophagus; 2023 Jul; 36(7):. PubMed ID: 36544426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
    Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
    Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Attention-Deficit/Hyperactivity Disorder with Medication in Children with Autism Spectrum Disorder With and Without Intellectual Disability: A DBPNet Study.
    Grater JE; Muniz EI; Silver EJ; Blum NJ; Shults J; Stein REK
    J Autism Dev Disord; 2023 Aug; 53(8):3144-3150. PubMed ID: 35633446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study.
    Hollis C; Chen Q; Chang Z; Quinn PD; Viktorin A; Lichtenstein P; D'Onofrio B; Landén M; Larsson H
    Lancet Psychiatry; 2019 Aug; 6(8):651-658. PubMed ID: 31221557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and treatment of mental, behavioral, and developmental disorders in children with co-occurring autism spectrum disorder and attention-deficit/hyperactivity disorder: A population-based study.
    Casseus M; Kim WJ; Horton DB
    Autism Res; 2023 Apr; 16(4):855-867. PubMed ID: 36644987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: A systematic review of the literature.
    Joshi G; Wilens T; Firmin ES; Hoskova B; Biederman J
    J Psychopharmacol; 2021 Mar; 35(3):203-210. PubMed ID: 33349107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining Trends and Coexisting Conditions Among Children Qualifying for SSI Under ADHD, ASD, and ID.
    Pulcini CD; Perrin JM; Houtrow AJ; Sargent J; Shui A; Kuhlthau K
    Acad Pediatr; 2015; 15(4):439-43. PubMed ID: 26142070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011.
    Song I; Shin JY
    Epidemiol Health; 2016; 38():e2016045. PubMed ID: 27866408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention Deficit Hyperactivity Disorder Symptoms in Young Children with Autism Spectrum Disorder.
    Hong JS; Singh V; Kalb L
    Autism Res; 2021 Jan; 14(1):182-192. PubMed ID: 33073542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.